ScholarWorks@Korea University College of Medicine: Kim, Sin Gon

Detailed Information

Kim, Sin Gon (김신곤)

Anam Hospital (Department of Endocrinology and Metabolism, Anam Hospital)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Diabetes mellitus:24||Metabolic syndrome:15||Type 2 diabetes:15||type 2:13||type 2 diabetes:11||metabolic syndrome:10||Inflammation:9||Atherosclerosis:8||insulin resistance:7||Diabetes mellitus, type 2:7||Cardiovascular disease:6||mortality:6||Cardiovascular diseases:6||North Korean refugees:6||Sarcopenia:5||Nonalcoholic fatty liver disease:4||Diabetes:4||North Korea:4||adiponectin:4||Obesity:4||Dipeptidylpeptidase IV inhibitors:4||variability:4||Dyslipidemias:4||Creactive protein:4||diabetes mellitus:4||Arterial stiffness:3||Metaanalysis:3||Hypertension:3||inflammation:3||Hypothyroidism:3||Albuminuria:3||Mortality:3||atherosclerosis:3||obesity:3||cardiovascular disease:3||Glycemic control:3||cardiovascular mortality:3||pheochromocytoma:3||Graves disease:3||Korea:3||Dementia:3||Osteoporosis:3||pulse wave velocity:3||sarcopenia:3||Thiazolidinediones:3||Pheochromocytoma:3||Positron emission tomography:3||Allcause mortality:3||Type 2 diabetes mellitus:3||Diabetic retinopathy:3||Fenofibrate:3||Pulse wave velocity:3||Hyperparathyroidism:3||glycaemic control:2||Active surveillance:2||positron emission tomography:2||prediabetes:2||Alzheimer disease:2||Statin:2||prevalence:2||Prognosis:2||Korean:2||Adiponectin:2||Vitamin D:2||Body mass index:2||Democratic People's Republic of Korea:2||Papillary thyroid microcarcinoma:2||Acromegaly:2||Sarcopenic obesity:2||Sulfonylurea:2||Epidemiology:2||dementia:2||Systematic review:2||LDL:2||Anthropometric index:2||diabetes:2||Cholesterol:2||VEGF:2||Diabetes complications:2||Cohort studies:2||Therapeutics:2||heart failure:2||Thyroid:2||Ezetimibe:2||Life style:2||Menopause:2||epidemiology:2||Insulin Resistance:2||stroke:2||Physical health:2||BRAF V600E mutation:2||AMPactivated protein kinase:2||Thyroid neoplasms:2||Heart failure:2||Incidence:2||Fibric acids:2||Lobeglitazone:2||interleukin6:2||Metformin:2||Dipeptidyl peptidaseIV inhibitors:2||Dipeptidyl peptidase4 inhibitors:2||Fasting plasma glucose:2||Diabetic nephropathies:2||Bone density:2||Prevalence:2||brain atrophy:2||nonalcoholic fatty liver disease:2||DPP4 inhibitor:2||COVID19:2||Malignant pleural effusion:2||ER stress:2||Body composition:2||older people:2||Glucose:2||Sleep duration:2||visceral obesity:2||visfatin:2||Glycemic variability:2||vitamin D:2||osteoporosis:2||Insulin resistance syndrome:2||Kidney failure, chronic:2||central obesity:2||Insulin resistance:2||clinical trial:2||Flash sensor glucose technology:1||Framingham risk score:1||Fulminant:1||GIP:1||GLP1:1||GPCR:1||Gender differences:1||Glomerular filtration rate:1||Glucagonlike peptide1 receptor agonist:1||Glucocorticoids:1||Glucose Intolerance:1||Glucose tolerance test:1||Glycaemic recovery:1||Glycaemic variability:1||Glycated hemoglobin A:1||Graves' disease:1||Gray matter:1||HDL:1||HEPATIC STEATOSIS:1||HIF1:1||HMGCoA reductase inhibitor:1||HbA1C:1||Health:1||Health for Korean Unification:1||Health inequities:1||Healthcare disparities:1||Hearing loss:1||Heart disease risk factors:1||Hematologic parameters:1||Hepatokine:1||Highsensitivity Creactive protein:1||Hip fractures:1||HydroxymethylglutarylCoA reductase inhibitors:1||HydroxymethylglutarylCoA reductase inhibitors:1||Hyperaldosteronism:1||Hyperfunction:1||Hyperglycemic hyperosmolar nonketotic coma:1||Hyperinsulinism:1||Hyperlipidemia:1||Hyperprolactinemia:1||Hypertriglyceridemia:1||Hypokalemia:1||Hypopituitarism:1||Ibandronate:1||Impaired glucose tolerance:1||Inconsistent mediation:1||Insulin:1||Insulin antibodies:1||Insulin glargine:1||Insulin secretion:1||Insulin sensitizer:1||Insulin therapy:1||Intraabdominal fat:1||Intraoperative parathyroid hormone assay:1||Intraoperative parathyroid hormone level:1||Iodine:1||Jet lag syndrome:1||Klebsiella pneumoniae:1||Korea National Health and Nutrition Examination Survey VI:1||Korean National Health Insurance Corporation:1||Korean Peninsula Health Community:1||Korean population:1||Koreans:1||Lcarnitine:1||LIPOAPOPTOSIS:1||Left ventricular hypertrophy:1||Leptin:1||Leukocyte cellderived chemotaxin 2:1||Lifestyle intervention:1||Lifestyle modification:1||Lipids:1||Lisinopril:1||Liver cirrhosis:1||Long term adverse effects:1||Longacting formulation of lanreotide:1||Low income:1||Low skeletal muscle mass:1||Lowdensity lipoprotein cholesterol:1||Lyn kinase agonism:1||MHO:1||Major depressive disorder:1||Medical Journals:1||Medical Research:1||Medullary thyroid carcinoma:1||Mental health:1||Metabolic health:1||Metabolic syndrome X:1||Metabolically abnormal but normal weight:1||Metabolically healthy but obese:1||Metrnl:1||Microalbuminuria:1||Midlife:1||Mixed meal tolerance test:1||Mobile applications:1||Multiple endocrine neoplasia 2A:1||Muscle:1||Muscle strength:1||Muscular diseases:1||NAcetylcysteine:1||N/A:1||NAFLD:1||NCT03061214:1||NONALCOHOLIC FATTY LIVER DISEASE:1||Nationwide:1||Neovascularization:1||Nerve conduction study:1||Network metaanalysis:1||North Korean Refugees:1||North Korean refugee:1||Nucleus accumbens:1||Obesity metabolism:1||Octreotide:1||Omega3 fatty acids:1||Orbital cellulitis:1||Osteoporotic fractures:1||PPAR alpha:1||Paraganglioma:1||Paraganglioma: Epidemiology:1||Parathyroid carcinoma:1||Parathyroid cyst:1||Parathyroid neoplasms:1||Parkinson's disease:1||Pericardial effusion:1||Peripheral artery disease:1||Peroxisome proliferatoractivated receptors:1||Phosphodiesterase inhibitor:1||Physician and patient behaviors:1||Pilot projects:1||Pooled cohort risk scores:1||Poorly differentiation攀접수일자: 2002년 2월 5일통과일자: 2002년 2월 25일:1||Postpartum hemorrhage:1||Posttraumatic stress disorder:1||Practice patterns, physicians’:1||Prediabetes:1||Pregnancy outcome:1||Proinflammatory reactions:1||Psychological adjustment:1||Public Health and Medical Care Cooperation:1||Quality of life:1||RAGE:1||RBC:1||REPUBLIC OF KOREA:1||RET protooncogene攀접수일자: 2003년 8월 5일통과일자: 2003년 10월 27일:1||Radioactive iodine therapy:1||Randomised trial:1||Real time continuous glucose monitoring system:1||Refugee:1||Refugees:1||Renal function:1||Renal insufficiency, chronic:1||Renin angiotensin system:1||Reninangiotensin system:1||Respiration:1||Resting heart rate:1||Rhabdomyolysis:1||Risk factors:1||Risk management:1||Risk stratification:1||Rosuvastatin calcium:1||Rubus occidentalis:1||SGLT2 inhibitor:1||Safety:1||Sclerostin:1||Selfmonitoring blood glucose:1||Semaglutide:1||Sesn2:1||Sestrin2:1||Sheehan's syndrome攀접수일자: 2006년 2월 3일통과일자: 2006년 3월 27일:1||Skeletal muscle:1||Skeletal muscle mass index:1||Sleep:1||Sleep apnea, obstructive:1||Sleep deprivation:1||Smallfiber neuropathy:1||Social impact:1||Sociocultural adjustment:1||Sodiumglucose transporter 2 inhibitors:1||SomatulinAutogel:1||SomatulinAutogelⓇ:1||South Korea:1||Statin duration:1||Statin intensity:1||Statins:1||Stroke:1||Subclinical Atherosclerosis:1||Subclinical atherosclerosis:1||Subclinical hypothyroidism:1||Suicidal ideation:1||Surrogate markers:1||TNFalpha:1||Telemedicine:1||Telmisartan:1||The Korean National Health Insurance Corporation:1||Thyroid autoantibody:1||Thyroid cancer:1||Thyroid cancer, anaplastic:1||Thyroid cancer, medullary:1||Thyroid gland· Carcinoma· Papillary.:1||Thyroid gland·Papillary·Carcinoma:1||Thyroid hormones:1||Thyroid papillary carcinoma:1||Thyroidstimulating hormone:1||Tie2:1||Tolimidone:1||Traumatic experience:1||Trend:1||Triglycerides:1||Tumor recurrence:1||Type 1 diabetes:1||Type 2:1||Type 2 diabetic rats:1||Type2 diabetes mellitus:1||Upper extremity:1||Valsartan:1||Value:1||Variability:1||Vascular adhesion molecules:1||Vascular inflammation:1||Venous thrombosis:1||Ventral pallidum:1||Visittovisit:1||WHO 2h criteria:1||Waisttohip ratio:1||Wessely and Powell score:1||Wnt pathway:1||abdominal:1||acromegaly:1||adipocytokines:1||adult:1||aging:1||albuminuria:1||anklebrachial pressure index:1||anthropometric index:1||antithyroid drug:1||antidiabetic drug:1||artificial:1||associated factors:1||beta cell function:1||betacell function:1||biomarker:1||black raspberry:1||blood pressure:1||body composition:1||body weight:1||body weight changes:1||bone density:1||cJun Nterminal kinase:1||cJun Nterminal kinases:1||calcium supplementation:1||cancer risk:1||cardiac risk factors and prevention:1||cardiovascular:1||cardiovascular disease (CVD):1||cardiovascular disease risk factors:1||carotid intima media thickness:1||catecholamine:1||chronic kidney diseases:1||clinical trials:1||cognition:1||cognitive decline:1||cohort study:1||combination:1||comorbidity:1||congenital:1||consensus:1||continuous glucose monitoring:1||continuous glucose monitoringdipeptidyl peptidase4 inhibitorevogliptinglycaemic variabilitylinagliptintype 2 diabetes:1||coronary artery disease:1||critical shear stress:1||crosssectional study:1||democratic people's republic of Korea:1||democratic people's republic of korea:1||depression:1||diabetes mellitus nephropathy:1||diet:1||digital health intervention:1||eating behaviors:1||ectopic:1||elderly:1||endstage kidney disease:1||epidemic:1||esRAGE:1||factor analysis:1||fatty liver disease:1||fenofibrate:1||fetuinA:1||fibroblast growth factor 1:1||food security:1||fracture:1||fulminant:1||gammaglutamyltransferase:1||ghrelin:1||glucagonlike protein 1 receptor agonist:1||glucose intolerance:1||glucose tolerance:1||glucose variability:1||glycemic variability:1||graves’ disease:1||gray matter:1||health:1||health disparity:1||health inequality:1||hemoglobin:1||hepatic steatosis index:1||highnormal blood pressure:1||highsensitivity Creactive protein:1||hyperglycaemia:1||hyperlipidemia:1||hyperparathyroidism:1||hypertension:1||hyperthyroidism:1||hypertriglyceridaemia:1||hyponatremia:1||hypophosphatemia:1||impaired glucose tolerance:1||incidence:1||insulin:1||insulin secretion:1||insulin sensitivity:1||interleukin10:1||ischemic ileitis:1||leukocyte telomere length:1||ligand selectivity:1||liver steatosis:1||lobeglitazone:1||low muscle mass:1||macroprolactinoma:1||medical cost:1||melatonin:1||metabolic diseases:1||metabolic risk management:1||metformin:1||mortality trend:1||multiple endocrine neoplasia type 2A:1||myocardial infarction:1||nationwide:1||nationwide study:1||night blood pressure:1||nonalcoholic fatty liver:1||nonobese:1||nutrient intake:1||obstructive sleep apnea:1||occupational health:1||omentin1:1||omeprazole:1||oral glucose tolerance test:1||osmotic demyelination syndrome:1||osteoblast:1||osteoclast:1||pancreas:1||paraganglioma:1||parathyroid adenoma:1||pediatrics:1||percentage body fat:1||physical activity intervention:1||pregnancy:1||prehypertension:1||proton pump inhibitor:1||proximal tubule cell:1||pulse wave:1||radioactive 131I therapy:1||radioactive iodine treatment (RAI treatment):1||radioiodine ablation:1||randomized controlled trial:1||randomized trial:1||recur:1||refugee:1||refugees:1||resistin:1||retrospective cohort study:1||risk factors:1||rosiglitazone:1||sFLT1:1||screening:1||short sleep duration:1||skeletal:1||skeletal muscle:1||skeletal muscle mass:1||sleep:1||sleep disordered breathing:1||socioeconomic status:1||sodiumglucose cotransporter 2 inhibitor:1||step counts:1||tea:1||therapeutics:1||thiazolidinediones:1||thyroid cancer:1||thyroid cancerspecific mortality:1||total cholesterol:1||treatment:1||type 1 diabetes mellitus:1||type 2 diabetes mellitus:1||vascular:1||vascular dementia:1||vascular endothelial growth factor:1||vascular inflammation:1||vildagliptin:1||wearable activity tracker:1||weight gain:1||weight loss:1||white blood cell count:1||women:1||zz:1||갑상선 유두암:1||갑상선·유두상 암종.:1||고인슐린증:1||당뇨병:1||메산지움:1||성장인자I:1||인슐린 자가 항체:1||인슐린양 말단비대증:1||저혈당:1||11βhydroxylase:1||흉막전이:1||25hydroxyvitamin D:1||ACTH syndrome:1||ADA fasting criteria:1||AMPK:1||ANGPTL3:1||ANGPTL8:1||Acetylcysteine:1||Acute Myocardial Infarction:1||Acute phase protein:1||Adiposity:1||Adrenal hyperplasia:1||Adrenalectomy:1||Adrenocortical adenoma:1||Adverse clinical outcome:1||Aldosterone receptor blocker:1||Aldosteronism:1||Alzheimer's dementia:1||Alzheimer's disease:1||Angiopoietin:1||Angiotensin receptor antagonists:1||Angiotensinconverting enzyme inhibitors:1||Anthropometry:1||Antipsychotic agents:1||Apoptosis:1||Asia:1||Asia Pacific:1||Asian people:1||Atorvastatin:1||Avandia:1||Bariatric surgery:1||Behavior:1||Behavior therapy:1||Biomedical research:1||Blood glucose:1||Blood glucose selfmonitoring:1||Blood pressure:1||Body fat composition:1||Body size phenotype:1||Body size phenotypes:1||Body temperature:1||Bone markers:1||Bone marrow metastasis:1||Bone muscle interaction:1||Brain atrophy:1||Bromocriptine:1||Brown tumor:1||BuddChiari syndrome:1||CHOP:1||Calcium:1||Carcinoma:1||Cardiocerebrovascular disease:1||Cardiometabolic risk factors:1||Cardiomyocytes:1||Cardiovascular mortality:1||Cardiovascular risk:1||Carotid artery ultrasonography:1||Carotid atherosclerosis:1||Casecontrol studies:1||Cellular phonne:1||Central diabetes insipidus:1||Chemerin:1||Cholecalciferol:1||Chronic kidney disease:1||Cilostazol:1||Circadian clocks:1||Circadian rhythm:1||Clinical trial:1||Cluster analysis:1||Common data model:1||Community networks:1||Comorbidity:1||Conflicts of interest:1||Congenital adrenal hyperplasia:1||Continuous glucose monitoring:1||Coronary artery calcification:1||Cortical laminar necrosis:1||Cortisol:1||Cost savings:1||Creatine kinase:1||Cutaneous silent period:1||DIabetes mellitus:1||DM nephropathy:1||DXA:1||Defection:1||Dementia, vascular:1||Depression:1||Diabetes complication:1||Diabetes education:1||Diabetes mellitus Glucose variability:1||Diabetes, gestational:1||Diabetic kidney disease:1||Diabetic nephropathy:1||Diabetic polyneuropathy:1||Diagnosis:1||Diet:1||Differentiated thyroid cancer:1||Dipeptidyl peptidase4 inhibitor:1||Drug therapy:1||Durability:1||Dyslipidaemias:1||Dyslipidemia:1||ER STRESS:1||Elderly:1||Elderly Koreans:1||Empty sella syndrome:1||Endstage renal disease:1||Endocrinology:1||Endothelial cells:1||Endothelium:1||Eosinophilia:1||Eplerenone:1||Estradiol:1||Eye infections, bacterial:1||F18fluorodeoxyglucose positron emission tomography:1||FTO polymorphism:1||Fasting blood glucose:1||Fasting glucose:1||Fasting hypoglycemia:1||Fasting plasma glucose variability:1||Fatigue:1||Fatigue scale:1||Fatty liver:1||Fitbit:1||Fitness trackers:1||

STATISTICS: Total View:; Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841) 82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE